← Back to catalogue

ImmuAdd

FDA UDI

Class II (US FDA UDI)

by Immucor, Inc.

Identity

Trade Name
ImmuAdd FDA UDI
Generic Name
Bovine serum albumin (BSA) immunohaematology reagent IVD FDA UDI
Device Name
ImmuAdd is intended for use as a potentiator in antibody detection, antibody identification and compatibility procedures. This product is prepared from glycine and salt-poor bovine albumin, and is the ten (10) vial configuration. FDA UDI
Model / Reference
0002008 FDA UDI
Description
ImmuAdd is intended for use as a potentiator in antibody detection, antibody identification and compatibility procedures. This product is prepared from glycine and salt-poor bovine albumin, and is the ten (10) vial configuration. FDA UDI

Identifiers

Catalog Number
0002008 FDA UDI
Primary DI / UDI-DI
10888234000167 FDA UDI
FDA Product Code
KSG FDA UDI
GMDN Term
Bovine serum albumin (BSA) immunohaematology reagent IVD FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.9600 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

Yes

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Bovine serum albumin (BSA) immunohaematology reagent IVD

ImmuAdd by Immucor, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Bovine serum albumin (BSA) immunohaematology reagent IVD.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Immucor, Inc.

Sources (1)

  • FDA UDI 23db5905-2bda-4dbd-8796-3ccee78b7e89 37 fields · synced May 30, 2026